MFI Stock Review: Cephalon (CEPH)
By MagicDiligence on Thu, 2009-11-05 08:07
(via www.magicdiligence.com)
Cephalon has three drugs with good growth potential. If sales develop according to the company's plan, the current price will prove to be a bargain.
Recent comments
2 days 3 hours ago
2 days 5 hours ago
2 days 21 hours ago
4 days 7 hours ago
6 days 5 hours ago
6 days 10 hours ago
1 week 2 days ago
4 weeks 2 days ago
5 weeks 3 days ago
7 weeks 6 days ago